George Schmid
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
George Schmid has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Brian Gerard Williams
SACEMA
2 shared publications Richard Steen
Departments of HIV/AIDS, World Health Organization, Geneva, Switzerland
2 shared publicationsAnne Buvé
1 shared publicationBasia Zaba
1 shared publication- Bertran Auvert
Affiliations: Institut National de la Santé et de la Recherche Médicale, Unit 1018, Centre for Research in Epidemiology and Population Health, Villejuif, France, Assistance Publique—Hôpitaux de Paris, Hôpital Ambroise Paré, Boulogne-Billancourt, France, Faculty of Medicine, University of Versailles-Saint Quentin, Versailles, France
1 shared publication Bradley P. Stoner
1 shared publication
Latest Publications
- 1 March 2009
- Published by WHO Press in Bulletin of the World Health Organization
- Vol. 87 (3) , 162
The unexplored story of HIV and ageing
- 1 March 2009
- Published by WHO Press in Bulletin of the World Health Organization
- Vol. 87 (3) , 162
The unexplored story of HIV and ageing
- 1 October 2008
- Published by WHO Press
- Vol. 86 (10) , 815
Bioviolence: preventing biological terror and crime
- 1 October 2008
- Published by WHO Press
- Vol. 86 (10) , 815
Bioviolence: preventing biological terror and crime
- 1 September 2008
- Published by WHO Press in Bulletin of the World Health Organization
- Vol. 86 (9) , 659
Adolescent boys: who cares?
- 1 September 2008
- Published by WHO Press in Bulletin of the World Health Organization
- Vol. 86 (9) , 659
Adolescent boys: who cares?
- Open Access
- 15 July 2008
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 198 (2) , 293-294
Who Will Bridge the HIV Treatment‐Prevention Gap?
To the Editor—On World AIDS Day 2007, the Journal published a supplement called “The Realities of Antiretroviral Therapy Rollout—Challenges to Successful Programmatic Implementation.” Surprisingly, none of the 14 articles in the supplement discusses in any meaningful way the importance of linking antiretroviral therapy (ART) services with the prevention of HIV infection. It is not that prevention was excluded from the mandate of the conference leading to the supplement—it seems simply to have been forgotten. After years of struggle for a comprehensive approach to the goal of “universal access to HIV treatment, care, prevention, and support” [1], it appears that the global discussion on linking and integrating the prevention of HIV infection with treatment and care has not fully reached clinicians and infectious diseases specialists.
- 15 July 2008
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 198 (2) , 293-294
Open AccessWho Will Bridge the HIV Treatment‐Prevention Gap?
To the Editor—On World AIDS Day 2007, the Journal published a supplement called “The Realities of Antiretroviral Therapy Rollout—Challenges to Successful Programmatic Implementation.” Surprisingly, none of the 14 articles in the supplement discusses in any meaningful way the importance of linking antiretroviral therapy (ART) services with the prevention of HIV infection. It is not that prevention was excluded from the mandate of the conference leading to the supplement—it seems simply to have been forgotten. After years of struggle for a comprehensive approach to the goal of “universal access to HIV treatment, care, prevention, and support” [1], it appears that the global discussion on linking and integrating the prevention of HIV infection with treatment and care has not fully reached clinicians and infectious diseases specialists.
- 1 July 2007
- Published by Wolters Kluwer Health in Sexually Transmitted Diseases
- Vol. 34 (7) , S5-S10
The Need and Plan for Global Elimination of Congenital Syphilis
In every society, congenital syphilis (CS) has significant medical, economic, societal and emotional burdens; these are poorly characterized but high. Inexplicably, the elimination of CS has failed to attract international attention. Yet, the cornerstones of programs to do this universally are in place, the recent development of new diagnostic tools offers the now-practical possibility of testing every pregnant woman, testing is cost-effective, and programs for the elimination of CS can be joined with other programs to enhance efficiency. The magnitude of the CS burden, globally, rivals that of HIV infection in neonates yet receives little attention. The newly proposed World Health Organization Strategy for the Global Elimination of Congenital Syphilis aims to mobilize resources and provide a plan to address this under-recognized health problem.
- 1 July 2007
- Published by Wolters Kluwer Health in Sexually Transmitted Diseases
- Vol. 34 (7) , S5-S10
The Need and Plan for Global Elimination of Congenital Syphilis
In every society, congenital syphilis (CS) has significant medical, economic, societal and emotional burdens; these are poorly characterized but high. Inexplicably, the elimination of CS has failed to attract international attention. Yet, the cornerstones of programs to do this universally are in place, the recent development of new diagnostic tools offers the now-practical possibility of testing every pregnant woman, testing is cost-effective, and programs for the elimination of CS can be joined with other programs to enhance efficiency. The magnitude of the CS burden, globally, rivals that of HIV infection in neonates yet receives little attention. The newly proposed World Health Organization Strategy for the Global Elimination of Congenital Syphilis aims to mobilize resources and provide a plan to address this under-recognized health problem.
- 15 May 2007
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 195 (10) , 1550-1551
Reply to Eisenhut
- 15 May 2007
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 195 (10) , 1550-1551
Reply to Eisenhut
- Open Access
- 15 March 2006
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 42 (6) , 889
Reply to Romoren and Sundby
Sir—We appreciate the comments by Romoren and Sundby [1] and their careful reading of the article by Paz-Bailey et al. [2] and our accompanying editorial [3]. In their comments, Drs. Romoren and Sundby raise 3 issues.
- 15 March 2006
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 42 (6) , 889
Open AccessReply to Romoren and Sundby
Sir—We appreciate the comments by Romoren and Sundby [1] and their careful reading of the article by Paz-Bailey et al. [2] and our accompanying editorial [3]. In their comments, Drs. Romoren and Sundby raise 3 issues.
- Open Access
- 1 November 2005
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 41 (9) , 1313-1315
Control of bacterial sexually transmitted diseases in the developing world is possible.
Paz-Bailey et al. 1 provide evidence from yet another country of the feasibility of moving from a situation of poor sexually transmitted disease (STD) control, characterized by high prevalences of curable bacterial and protozoan STDs, to one of lower prevalences. An important feature of this change is a decrease in the number of cases of genital ulcers and a predictably changing etiology; as control measures (most effective against bacteria) decrease the proportion of genital ulcers due to Haemophilus ducreyi (in particular) and Treponema pallidum, ulcers of herpetic origin become predominant. This transition toward STD patterns typical of industrialized countries is good news, in that interventions are having an impact on STD transmission and, surely, their sequelae (e.g., infertility), and are likely decreasing the rate of HIV transmission as well.
- 1 November 2005
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 41 (9) , 1313-1315
Open AccessControl of bacterial sexually transmitted diseases in the developing world is possible.
Paz-Bailey et al. 1 provide evidence from yet another country of the feasibility of moving from a situation of poor sexually transmitted disease (STD) control, characterized by high prevalences of curable bacterial and protozoan STDs, to one of lower prevalences. An important feature of this change is a decrease in the number of cases of genital ulcers and a predictably changing etiology; as control measures (most effective against bacteria) decrease the proportion of genital ulcers due to Haemophilus ducreyi (in particular) and Treponema pallidum, ulcers of herpetic origin become predominant. This transition toward STD patterns typical of industrialized countries is good news, in that interventions are having an impact on STD transmission and, surely, their sequelae (e.g., infertility), and are likely decreasing the rate of HIV transmission as well.
- 1 June 2004
- Vol. 82 (6) , 402-9
Economic and programmatic aspects of congenital syphilis prevention.
A review of the economic and programmatic aspects of congenital syphilis was conducted and recommendations made for improvement of its prevention. Congenital syphilis is a preventable disease and the tools to prevent it have been available for decades. In both industrialized and developing countries, but particularly the latter, the prevention of congenital syphilis by antenatal screening is cost-effective and may be cost-saving. Yet, globally, there are probably >500 000 fetal deaths a year from congenital syphilis, a figure rivalling that from mother-to-child transmission of human immunodeficiency virus (HIV), which receives far greater attention. The reasons that congenital syphilis persists vary, with international and national under-appreciation of the burden of congenital syphilis and insufficient political will to provide effective antenatal screening programmes probably being the main reasons. All causes are amenable to effective intervention programmes. The prevention of congenital syphilis should be a global priority; international agencies and national programmes should be committed to improving antenatal care (ANC) services including syphilis detection and prevention.
- 1 June 2004
- Vol. 82 (6) , 402-9
Economic and programmatic aspects of congenital syphilis prevention.
A review of the economic and programmatic aspects of congenital syphilis was conducted and recommendations made for improvement of its prevention. Congenital syphilis is a preventable disease and the tools to prevent it have been available for decades. In both industrialized and developing countries, but particularly the latter, the prevention of congenital syphilis by antenatal screening is cost-effective and may be cost-saving. Yet, globally, there are probably >500 000 fetal deaths a year from congenital syphilis, a figure rivalling that from mother-to-child transmission of human immunodeficiency virus (HIV), which receives far greater attention. The reasons that congenital syphilis persists vary, with international and national under-appreciation of the burden of congenital syphilis and insufficient political will to provide effective antenatal screening programmes probably being the main reasons. All causes are amenable to effective intervention programmes. The prevention of congenital syphilis should be a global priority; international agencies and national programmes should be committed to improving antenatal care (ANC) services including syphilis detection and prevention.
- 1 February 2004
- Published by Elsevier in The Lancet
- Vol. 363 (9407) , 482-488
Transmission of HIV-1 infection in sub-Saharan Africa and effect of elimination of unsafe injections
- 1 February 2004
- Published by Elsevier in The Lancet
- Vol. 363 (9407) , 482-488
Transmission of HIV-1 infection in sub-Saharan Africa and effect of elimination of unsafe injections